Mucinex Childrens Mighty Chews Night Time Cold and Flu

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including minor aches and pains, sore throat, headache, cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants, runny nose, and sneezing. Additionally, it temporarily reduces fever and controls cough to facilitate sleep.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients should adhere strictly to the recommended dosage and administration guidelines. It is imperative not to exceed the directed dosage, and healthcare professionals should refer to the Overdose warning for further information.

For administration, the chewable tablets must be chewed thoroughly before swallowing. The dosing intervals are every 4 hours, or as directed by a healthcare provider.

Dosage Recommendations:

• Adults and Children Aged 12 Years and Over: The recommended dosage is 4 chewable tablets every 4 hours. The total daily limit should not exceed 6 doses, equating to a maximum of 24 chewable tablets within a 24-hour period.

• Children Aged 6 to Under 12 Years: The recommended dosage is 2 chewable tablets every 4 hours. The total daily limit should not exceed 5 doses, which corresponds to a maximum of 10 chewable tablets in a 24-hour period.

• Children Under 6 Years of Age: The use of this medication is not recommended for children under 6 years of age.

Healthcare professionals should ensure that patients understand these guidelines to promote safe and effective use of the medication.

Contraindications

Use is contraindicated in pregnant or breastfeeding individuals unless directed by a healthcare professional.

The product should be kept out of reach of children to prevent accidental ingestion.

Additionally, the use of this product is contraindicated in cases of overdose, as taking more than the recommended dose may lead to liver damage. In the event of an overdose, immediate medical assistance or contact with a Poison Control Center is necessary.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen, under the following circumstances: adults should not exceed 6 doses (24 chewable tablets) in a 24-hour period, while children should not exceed 5 doses (10 chewable tablets) in the same timeframe. The risk of liver damage is heightened if this product is taken concurrently with other medications containing acetaminophen or if an adult consumes 3 or more alcoholic drinks daily while using this product.

Acetaminophen may also lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative to discontinue use immediately and seek medical assistance. Additionally, if a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a healthcare provider is advised.

This product should not be used to induce sleep in children or in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a doctor or pharmacist is recommended. Furthermore, this product should not be used by individuals currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such medication.

Healthcare professionals should advise patients to consult a doctor before using this product if they have liver disease, are on a sodium-restricted diet, have glaucoma, suffer from breathing problems such as emphysema or chronic bronchitis, experience difficulty urinating due to prostate enlargement, or if the patient is a child with arthritis-related pain. Additionally, patients should seek guidance from a doctor or pharmacist if they are taking the anticoagulant warfarin or any sedatives or tranquilizers.

While using this product, it is crucial to adhere strictly to the recommended dosage to avoid overdose. Users may experience excitability, particularly in children, and marked drowsiness may occur. The sedative effects can be exacerbated by alcohol, sedatives, and tranquilizers; therefore, the consumption of alcoholic beverages should be avoided. Caution is advised when driving or operating machinery.

In the event of an overdose, immediate medical attention is essential. Patients should contact a Poison Control Center or seek emergency medical help without delay, as prompt intervention is critical for both adults and children, even in the absence of noticeable symptoms.

Patients should discontinue use and contact a healthcare provider if pain or cough worsens or persists beyond 5 days for children or 7 days for adults, if fever worsens or lasts more than 3 days, if redness or swelling occurs, if new symptoms arise, or if a cough recurs with a rash or headache that lasts, as these may indicate a serious condition.

Side Effects

Severe liver damage may occur in patients who exceed the recommended dosage of this product. Specifically, adults should not take more than 6 doses (24 chewable tablets) in a 24-hour period, while children should not exceed 5 doses (10 chewable tablets) within the same timeframe. The risk of liver damage is further heightened if the product is taken in conjunction with other medications containing acetaminophen or if the adult consumes 3 or more alcoholic drinks daily while using this product.

Patients should be aware of the potential for severe skin reactions associated with acetaminophen. Symptoms of such reactions may include skin reddening, blisters, and rash.

During the use of this product, excitability may occur, particularly in children. Additionally, marked drowsiness has been reported, which may be exacerbated by the consumption of alcohol, sedatives, or tranquilizers. Patients are advised to avoid alcoholic beverages and to exercise caution when driving or operating machinery due to the increased risk of drowsiness.

Patients should discontinue use and consult a healthcare professional if pain or cough worsens or persists beyond 5 days in children or 7 days in adults, if fever worsens or lasts more than 3 days, if redness or swelling is observed, if new symptoms arise, or if a cough recurs or is accompanied by a rash or headache lasting longer than expected. These symptoms may indicate a serious condition requiring medical attention.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mucinex Childrens Mighty Chews Night Time Cold and Flu (acetaminophen, dextromethorphan hbr and doxylamine succinate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should not use this medication. For children aged 6 to under 12 years, the recommended dosage is 2 chewable tablets every 4 hours, with a maximum of 5 doses (10 chewable tablets) in a 24-hour period. In contrast, adults and children aged 12 years and older may take 4 chewable tablets every 4 hours, not exceeding 6 doses (24 chewable tablets) in a 24-hour period.

Healthcare professionals should be aware of the liver warning associated with exceeding the maximum daily amount of 5 doses (10 chewable tablets) in children. Additionally, excitability may occur, particularly in pediatric patients, and marked drowsiness is also a potential side effect. If a child's pain or cough worsens or persists for more than 5 days, it is advised to discontinue use and consult a doctor.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. The maximum daily dosage for adults is 6 doses (24 chewable tablets) within a 24-hour period, while for children, the maximum is 5 doses (10 chewable tablets) in the same timeframe. Exceeding these limits may lead to significant hepatic injury.

Additionally, patients should be advised against the concurrent use of other medications containing acetaminophen, as this can further increase the risk of liver damage. Furthermore, adults who consume 3 or more alcoholic drinks daily while using this product are at an elevated risk for severe liver complications.

It is recommended that patients with known liver disease consult a healthcare professional prior to using this product to ensure safe and appropriate use. Regular monitoring of liver function may be warranted in patients with compromised liver function to detect any potential adverse effects promptly.

Overdosage

In cases of overdosage, significant health risks are associated with exceeding the recommended dosage of the medication.

Adult Overdosage Severe liver damage may occur in adults who consume more than 6 doses (equivalent to 24 chewable tablets) within a 24-hour period, which is the established maximum daily amount. It is imperative that healthcare professionals monitor patients for signs of liver impairment and advise them to adhere strictly to the prescribed dosage to mitigate the risk of overdose.

Pediatric Overdosage For pediatric patients, the risk of severe liver damage is similarly elevated. Children who take more than 5 doses (or 10 chewable tablets) in a 24-hour timeframe are at risk of experiencing significant hepatic injury. Healthcare providers should ensure that caregivers are aware of the maximum daily limits and the importance of following dosing instructions precisely.

Recommended Actions To prevent overdose, it is crucial to instruct patients and caregivers not to exceed the recommended dosage. In the event of suspected overdosage, immediate medical evaluation is warranted to assess liver function and initiate appropriate management strategies.

Nonclinical Toxicology

No relevant information was found regarding teratogenic effects, non-teratogenic effects, or any aspects of nonclinical toxicology. Additionally, there is no available data pertaining to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified the potential for severe skin reactions associated with acetaminophen use. Reported symptoms of these reactions include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use and seek medical assistance immediately.

Additionally, it is recommended to stop use and consult a healthcare professional if any of the following occur: worsening pain or cough lasting more than 5 days in children or 7 days in adults; fever that worsens or persists for more than 3 days; presence of redness or swelling; emergence of new symptoms; or recurrence of cough accompanied by rash or headache lasting longer than usual, as these may indicate a serious condition.

Furthermore, an overdose warning has been issued, indicating that exceeding the recommended dosage may lead to liver damage. In cases of suspected overdose, it is crucial to seek medical help or contact a Poison Control Center promptly, as timely medical intervention is essential for both adults and children, even in the absence of noticeable signs or symptoms.

Patient Counseling

Healthcare providers should advise patients to consult a health professional if they are pregnant or breastfeeding before using this medication. It is important to emphasize the necessity of keeping the medication out of reach of children to prevent accidental ingestion.

Providers should also inform patients about the risks associated with overdose. Patients must be made aware that taking more than the recommended dose can lead to liver damage. In the event of an overdose, it is crucial for patients to seek medical help or contact a Poison Control Center immediately. Prompt medical attention is essential for both adults and children, even if no signs or symptoms are initially apparent.

Storage and Handling

The product is supplied in a package that is suitable for healthcare professionals. It should be stored in a cool, dry place, maintaining a temperature range of 20-25°C (68-77°F) to ensure optimal stability and efficacy. Proper storage conditions are essential to preserve the integrity of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mucinex Childrens Mighty Chews Night Time Cold and Flu, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)